Soon, harsher penalties for submitting false data for drug approval Farhat Nasim11 Oct 2024 3:04 PM ISTNew Delhi: Soon, there will be a stringent action against pharma companies who submit forged or false data for drug approval for sales in the...
No therapeutic justification: Central Government bans 14 FDCs for human use Susmita Roy3 Jun 2023 1:31 PM ISTNew Delhi: In accordance with the recommendation, "no therapeutic justification" made by the Expert Committee and the Drugs Technical Advisory Board,...
CDSCO seeks details of 16 FDCs named as irrational for further examination Farhat Nasim13 April 2023 1:30 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a notice seeking all the manufacturers of the 16 Fixed Dose Combinations...
Union Health Ministry notifies 300 drug brands under Schedule H2, Details Farhat Nasim21 Nov 2022 5:38 PM ISTNew Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra,...
DTAB agrees change of Allergan India Refresh Tears from prescription drug to OTC Roshni Dhar28 Oct 2022 6:30 PM ISTGranting drug maker Allergan India request to change the category of "Refresh Tears" from prescription drug to over the counter drug, the Drug...
Health Bulletin 28/October/2022 Roshni Dhar28 Oct 2022 4:36 PM ISTHere are the top health news for the day:Presence of Carcinogen Benzene: Dove, other Unilever Shampoos recalledUnilever has recalled popular brands of...
No need of prescription from Doctors for Refresh Tears: DTAB Dr. Divya Colin27 Oct 2022 6:00 PM ISTNew Delhi: Granting drug maker Allergan India request to change the category of "Refresh Tears" from prescription drug to over the counter drug, the...
Denying Abbott proposal DTAB rules Zolpidem continues to be Schedule H1 drug Dr. Divya Colin25 Oct 2022 11:30 AM ISTNew Delhi: Denying the pharma major Abbott India proposal to change schedule of Zolpidem Tartrate from Schedule H1 to Schedule H of the Drugs Rules,...
DTAB to exempt antiseptics from sale license Medical Dialogues Team16 Jun 2021 4:26 PM ISTNew Delhi: Holding that liquid antiseptics should not be restricted to licensed premises but should be permitted to be sold in all shops, especially...
DTAB recommends adding psoriasis drug Acitretin in Schedule H of Drugs Rules, 1945 Medical Dialogues Team11 May 2021 6:00 PM ISTNew Delhi: After considering the serious teratogenicity effect of Acitretin, a systemic retinoid prescribed particularly in dermatological diseases,...
DTAB rejects proposal to mandate printing drug labels in Hindi, regional languages Medical Dialogues Team10 May 2021 3:46 PM ISTNew Delhi: Citing the proposal impractical, the Drugs Technical Advisory Board (DTAB) has declined to permit drug labels to be printed in Hindi or...
Examine 16 irrational FDCs for further submission: Health Ministry to DTAB constituted sub-committee Medical Dialogues Team5 May 2021 5:21 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) constituted sub-committee has been directed by the Union Health Ministry to examine 16 irrational...
